Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines
Anne E. Dodson, Sol Shenker, Pamela Sullivan, Sumeet U. Nayak, Chris Middleton, Michael McGuire, Edmond Chipumuro, Yuji Mishina, Erica R. Tobin, Louise Cadzow, Andrew A. Wylie, Dipen Sangurdekar · 2024
Read Pan-Cancer Analysis of Homologous Recombination Deficiency in Cell Lines by Anne E. Dodson, Sol Shenker, Pamela Sullivan, Sumeet U. Nayak, Chris Middleton, Michael McGuire, Edmond Chipumuro, Yuji Mishina, Erica R. Tobin, Louise Cadzow, Andrew A. Wylie, Dipen Sangurdekar (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11621922.txt.
Description
Anne Dodson and co-authors survey a DNA repair defect across cancer cell lines in a 2024 paper. When cells cannot repair DNA by homologous recombination, their genomes become unstable. That same defect makes tumors vulnerable to drugs such as PARP inhibitors, so it is a useful marker in cancer care.
Several computer methods predict the defect, but few had been applied broadly to cell lines. The team used two such methods across many lines and cancer types. A wide map of the defect in cell lines helps researchers pick the right models for testing new DNA-damaging treatments.
Catalog record
| CREATOR | Anne E. Dodson, Sol Shenker, Pamela Sullivan, Sumeet U. Nayak, Chris Middleton, Michael McGuire, Edmond Chipumuro, Yuji Mishina, Erica R. Tobin, Louise Cadzow, Andrew A. Wylie, Dipen Sangurdekar |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 67 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |